Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 USD | +0.82% | -10.76% | +119.88% |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
May. 06 | Rate Cut Hopes Lift Exchange-Traded Funds, Equity Futures Pre-Bell Monday | MT |
Financials (USD)
Sales 2024 * | 77.71M | Sales 2025 * | 92.23M | Capitalization | 353M |
---|---|---|---|---|---|
Net income 2024 * | -171M | Net income 2025 * | -161M | EV / Sales 2024 * | 2.87 x |
Net cash position 2024 * | 130M | Net cash position 2025 * | 88.83M | EV / Sales 2025 * | 2.87 x |
P/E ratio 2024 * |
-1.99
x | P/E ratio 2025 * |
-2.33
x | Employees | 274 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.36% |
Latest transcript on ADC Therapeutics SA
1 day | -0.68% | ||
1 week | -10.76% | ||
Current month | -17.23% | ||
1 month | -26.56% | ||
3 months | -22.01% | ||
6 months | +395.25% | ||
Current year | +119.88% |
Managers | Title | Age | Since |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 22-05-08 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 22-12-18 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 19-05-31 |
Ron Squarer
CHM | Chairman | 57 | 20-03-31 |
Jean Bizzari
BRD | Director/Board Member | 69 | 22-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 3.65 | -0.54% | 98 246 |
24-05-22 | 3.67 | -1.61% | 400,347 |
24-05-21 | 3.73 | -9.25% | 1,018,261 |
24-05-20 | 4.11 | +0.24% | 317,201 |
24-05-17 | 4.1 | +0.24% | 411,310 |
Delayed Quote Nyse, May 23, 2024 at 10:19 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+119.88% | 353M | |
+10.63% | 115B | |
+12.26% | 106B | |
-5.59% | 24.69B | |
-1.60% | 21.97B | |
-5.24% | 19.27B | |
-11.04% | 17.56B | |
-39.36% | 17.32B | |
+5.91% | 14.03B | |
+33.49% | 12.13B |
- Stock Market
- Equities
- ADCT Stock